Goldy C. George
1
, PhD ;
Eucharia C. Iwuanyanwu
1
, PHS, MPAS, PAC ;
Adrianna S. Buford
1
, MPH ;
Sarina A. Piha-Paul
1
, MD ;
Vivek Subbiah
1
, MD ;
Siqing Fu
1
, MD ;
Daniel D. Karp
1
, MD ;
Shubham Pant
1
, MBBS ;
Christina O. Hinojosa
1
, MS, CCRP ;
Kenneth R. Hess
2
, MS, PhD ;
Charles S. Cleeland
3
, PhD ;
Elmer V. Bernstam
4
, MD, MSE ;
Funda Meric-Bernstam
1
, MD ;
David S. Hong
1
, MD
1
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
2
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
3
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
4
School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States
Corresponding Author:
-
Goldy C. George, PhD
-
Department of Investigational Cancer Therapeutics
-
The University of Texas MD Anderson Cancer Center
-
Houston, TX
-
United States
-
Phone:
1 7137941347
-
Email: ggeorge2@mdanderson.org